Cargando…
2273. Azithromycin Use Before and During COVID- 19 and Impact of Implementing Evidence-based Guidelines
BACKGROUND: Early in the COVID-19 pandemic, results from small uncontrolled studies led to azithromycin being proposed as an effective treatment in patients with COVID-19. Numerous subsequent randomized controlled trials and observational studies have failed to demonstrate azithromycin’s effectivene...
Autores principales: | Shams, Sherin, Nafady-Hego, Hanaa, Thomas, Anil G, Saleem, Samah, Hanana, Fathima, Malik, Aimon, Kaleeckal, Anvar Hassan, Latif, Ali Nizar, Umar, Aftab Mohammad, Alkhal, Abdullatif, Almaslamani, Muna, Abou-Samra, Abdul-Badi, Butt, Adeel A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678686/ http://dx.doi.org/10.1093/ofid/ofad500.1895 |
Ejemplares similares
-
Outcomes Among Patients with Breakthrough SARS-CoV-2 Infection After Vaccination
por: Butt, Adeel A., et al.
Publicado: (2021) -
Immediate and contributory causes of death in patients hospitalized with COVID-19
por: Butt, Adeel A., et al.
Publicado: (2023) -
Risk factors for breakthrough SARS-CoV-2 infection in vaccinated healthcare workers
por: Alishaq, Moza, et al.
Publicado: (2021) -
COVID-19 disease severity in persons infected with the Omicron variant compared with the Delta variant in Qatar
por: Butt, Adeel A, et al.
Publicado: (2022) -
2273 Synthetic cannabinoid usage among psychiatric inpatients
por: Mann, Claire L., et al.
Publicado: (2018)